Moreover, CENPL was detected as one of the novel hub genes and served as a prognostic marker candidate in breast cancer [48], and high expression of CCNB2 in breast carcinoma showed an association with disadvantageous clinical outcomes [49]. This evidence concerns the gene CENPL and breast carcinoma.